[1]
|
Malik, Y.S., Sircar, S., Bhat, S., et al. (2020) Emerging Novel Coronavirus (2019-NCoV)-Current Scenario, Evolu-tionary Perspective Based on Genome Analysis and Recent Developments. The Veterinary Quarterly, 40, 68-76.
https://doi.org/10.1080/01652176.2020.1727993
|
[2]
|
Hu, B., Guo, H., Zhou, P., et al. (2021) Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology, 19, 141-154. https://doi.org/10.1038/s41579-020-00459-7
|
[3]
|
Rehman, U.S., Shafique, L., Ihsan, A., et al. (2020) Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2. Pathogens, 9, 240-240. https://doi.org/10.3390/pathogens9030240
|
[4]
|
Goh, K.G., Dunker, K.A., Foster, A.J., et al. (2020) Shell Disorder Analysis Predicts Greater Resilience of the SARS-CoV-2 (COVID-19) outside the Body and in Body Fluids. Microbial Pathogenesis, 144, Article ID: 104177.
https://doi.org/10.1016/j.micpath.2020.104177
|
[5]
|
Petersen, E., Koopmans, M., Go, U., et al. (2020) Comparing SARS-CoV-2 with SARS-CoV and Influenza Pandemics. The Lancet Infectious Diseases, 20, E238-E244. https://doi.org/10.1016/S1473-3099(20)30484-9
|
[6]
|
Wu, F., Zhao, S., Yu, B., et al. (2020) A New Coronavirus Associated with Human Respiratory Disease in China. Nature, 579, 265-269. https://doi.org/10.1038/s41586-020-2008-3
|
[7]
|
De Giorgio, A. (2020) Global Psychological Implications of Se-vere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease-2019 (COVID-19). What Can Be Learned from Italy. Reflections, Perspectives, Opportunities. Frontiers in Psychology, 11, Article No. 1836.
|
[8]
|
Nikolich-Zugich, J., Knox, K.S., Rios, C., et al. (2020) Correction to: SARS-CoV-2 and COVID-19 in Older Adults: What We May Expect Regarding Pathogenesis, Immune Responses, and Outcomes. GeroScience, 42, Arti-cle No. 1013.
https://doi.org/10.1007/s11357-020-00193-1
|
[9]
|
丁彦青, 卞修武. 从SARS尸体解剖发现, 浅析冠状病毒性疾病-19(COVID-19) [J]. 中华病理学杂志, 2020(49): e003.
|
[10]
|
Mahmudpour, M., Roozbeh, J., Keshavarz, M., et al. (2020) COVID-19 Cytokine Storm: The Anger of Inflammation. Cytokine, 133, Article ID: 155151. https://doi.org/10.1016/j.cyto.2020.155151
|
[11]
|
Ni, W., et al. (2020) Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19. Critical Care (London, England), 24, Article No. 422. https://doi.org/10.1186/s13054-020-03120-0
|
[12]
|
Narayan, A., et al. (2020) Pathophysiology of COVID-19-Associated Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 9, E3. https://doi.org/10.1016/S2213-2600(20)30509-9
|
[13]
|
Gusev, E., Sarapultsev, A., Hu, D. and Chereshnev, V. (2021) Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). International Journal of Molecular Sciences, 22, 7582-7582. https://doi.org/10.3390/ijms22147582
|
[14]
|
Asakura, H. and Ogawa, H. (2020) COVID-19-Associated Coag-ulopathy and Disseminated Intravascular Coagulation. International Journal of Hematology, 113, 45-57. https://doi.org/10.1007/s12185-020-03029-y
|
[15]
|
Dhama, K., Khan, S., Tiwari, R., et al. (2020) Coronavirus Disease 2019-COVID-19. Clinical Microbiology Reviews, 33, e00028-20. https://doi.org/10.1128/CMR.00028-20
|
[16]
|
Lu, R.J., Zhao, X., Li, J., et al. (2020) Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. The Lancet, 395, 565-574.
|
[17]
|
Meini, S., Zanichelli, A., Sbrojavacca, R., et al. (2020) Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? Frontiers in Immunology, 11, Article No. 2014.
|
[18]
|
Jin, Y., Yang, H., Ji, W., et al. (2020) Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses, 12, Article No. 372. https://doi.org/10.3390/v12040372
|
[19]
|
Nooh, F., Utzinger, J., Paris, D.H., et al. (2023) Association of Hyper-tension, Diabetes, and Cardiovascular Disease with COVID-19 in Africa: Scoping Review Protocol. Tropical Medicine and Infectious Disease, 8, Article No. 293.
https://doi.org/10.3390/tropicalmed8060293
|
[20]
|
Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
|
[21]
|
Levi, M. and Scully, M. (2018) How I Treat Disseminated Intravascular Coagulation. Blood, 131, 845-854.
https://doi.org/10.1182/blood-2017-10-804096
|
[22]
|
Liu, Y., Gao, W., Guo, W., et al. (2020) Prominent Coagula-tion Disorder Is Closely Related to Inflammatory Response and Could Be as a Prognostic Indicator for ICU Patients with COVID-19. Journal of Thrombosis and Thrombolysis, 50, 825-832. https://doi.org/10.1007/s11239-020-02174-9
|
[23]
|
Chen, A.-T., Wang, C.-Y., Zhu, W.-L., et al. (2022) Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review. Aging and Disease, 13, 144-156.
https://doi.org/10.14336/AD.2021.0704
|
[24]
|
Mucha, S.R., Dugar, S., et al. (2020) Update to Coagulopathy in COVID-19: Manifestations and Management. Cleveland Clinic Journal of Medicine.
|
[25]
|
Cui, S.P., Chen, S., Li, X.N., et al. (2020) Prevalence of Venous Thromboembolism in Patients with Severe Novel Coronavirus Pneumonia. Journal of Thrombosis and Haemostasis: JTH, 18, 1421-1424. https://doi.org/10.1111/jth.14830
|
[26]
|
Klok, F., Kruip, M., Meer, D.V.N., et al. (2020) Incidence of Thrombotic Complications in Critically Ill ICU Patients with COVID-19. Thrombosis Research, 191, 145-147. https://doi.org/10.1016/j.thromres.2020.04.013
|
[27]
|
Middeldorp, S., Coppens, M., Van Haaps, T.F., et al. (2021) Incidence of Venous Thromboembolism in Hospitalized Patients with COVID-19. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 9, Article No. 536.
https://doi.org/10.1016/j.jvsv.2020.12.004
|
[28]
|
Kollias, A., Kyriakoulis, K.G., et al. (2020) Thromboembolic Risk and Anticoagulant Therapy in COVID-19 Patients: Emerging Evidence and Call for Action. British Journal of Haematology, 189, 846-847.
https://doi.org/10.1111/bjh.16727
|
[29]
|
Arachchillage, D.R.J. and Laffan, M. (2020) Abnormal Coagulation Pa-rameters Are Associated with Poor Prognosis in Patients with Novel Coronavirus Pneumonia. Journal of Thrombosis and Haemostasis: JTH, 18, 1233-1234.
https://doi.org/10.1111/jth.14820
|
[30]
|
Mamta, S., Ram, G., Raju, V., et al. (2020) D-Dimer Level Is a Useful Pre-dictor for Mortality in Patients with COVID-19: Analysis of 483 Cases. Diabetes Metabolic Syndrome: Clinical Re-search Reviews, 14, 2245-2249.
https://doi.org/10.1016/j.dsx.2020.11.007
|
[31]
|
Rostami, M. and Mansouritorghabeh, H. (2020) D-Dimer Level in COVID-19 Infection: A Systematic Review. Expert Review of Hematology, 13, 1265-1275. https://doi.org/10.1080/17474086.2020.1831383
|
[32]
|
Chawda, N., Jain, S., Solanki, B., et al. (2023) D-Dimer: A Primer Biomarker in COVID-19. Asian Journal of Medicine and Health, 21, 107-113. https://doi.org/10.9734/ajmah/2023/v21i10883
|
[33]
|
Tahir, M.J., Yasmin, F., et al. (2023) Association of D-Dimer Levels with In-Hospital Outcomes among COVID-19 Positive Patients: A Developing Country Multicenter Retrospec-tive Cohort. Annals of Medicine and Surgery (2012), 85, 1527-1533.
|
[34]
|
Hayıroğlu, M.İ., et al. (2020) Fibrinogen and D-Dimer Variances and Anticoagulation Recommendations in Covid-19: Current Literature Review. Revista Da Associacao Medica Brasileira (1992), 66, 842-848.
https://doi.org/10.1590/1806-9282.66.6.842
|
[35]
|
Levi, M., et al. (2009) Guidelines for the Diagnosis and Man-agement of Disseminated Intravascular Coagulation. British Committee for Standards in Haematology. British Journal of Haematology, 145, 24-33.
https://doi.org/10.1111/j.1365-2141.2009.07600.x
|
[36]
|
Han, H., Yang, L., Liu, R., et al. (2020) Prominent Changes in Blood Coagulation of Patients with SARS-CoV-2 Infection. Clinical Chemistry and Laboratory Medicine, 58, 1116-1120. https://doi.org/10.1515/cclm-2020-0188
|
[37]
|
Di Micco, P., Russo, V., Carannante, N., et al. (2020) Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study. Journal of Clinical Medicine, 9, Article No. 4134.
https://doi.org/10.3390/jcm9124134
|
[38]
|
Sui, J.R., Noubouossie, D.F., et al. (2021) Elevated Plasma Fibrinogen Is Associated with Excessive Inflammation and Disease Severity in COVID-19 Patients. Frontiers in Cellular and Infection Microbiology, 11, Article ID: 734005.
https://doi.org/10.3389/fcimb.2021.734005
|
[39]
|
Citu, C., Burlea, B., Gorun, F., et al. (2022) Predictive Value of Blood Coagulation Parameters in Poor Outcomes in COVID-19 Patients: A Retrospective Observational Study in Ro-mania. Journal of Clinical Medicine, 11, 2831-2831.
https://doi.org/10.3390/jcm11102831
|
[40]
|
Papadopoulos, N., Vasileiadi, S. and Deutsch, M. (2020) COVID-19 and Liver Injury: Where Do We Stand? Annals of Gastroenterology, 33, 459-464.
|
[41]
|
Sivandzadeh, G.R., Askari, H., Safarpour, A.R., et al. (2021) COVID-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mecha-nisms, Treatment, and Management Challenges. World Journal of Clinical Cases, 9, 6178-6200.
https://doi.org/10.12998/wjcc.v9.i22.6178
|
[42]
|
Mustafa, I.M., Abdelmoneim, H.A., Mahmoud, M.E., et al. (2020) Cytokine Storm in COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Deter-gent-Free Chemokine Receptors. Mediators of Inflammation, 2020, Article ID: 8198963. https://doi.org/10.21467/preprints.139
|
[43]
|
Ali, F.E.M., Mohammedsaleh, Z.M., Ali, M.M., et al. (2021) Impact of Cytokine Storm and Systemic Inflammation on Liver Impairment Patients Infected by SARS-CoV-2: Prospective Therapeutic Challenges. World Journal of Gastroenterology, 27, 1531-1552. https://doi.org/10.3748/wjg.v27.i15.1531
|
[44]
|
Fan, Z., Chen, L., Li, J., et al. (2020) Clinical Features of COVID-19-Related Liver Functional Abnormality. Clinical Gastroenterology and Hepatology, 18, 1561-1566. https://doi.org/10.1016/j.cgh.2020.04.002
|
[45]
|
Harapan, H., Karunia, J.F., Supriono, S., et al. (2021) The Preva-lence, Predictors and Outcomes of Acute Liver Injury among Patients with COVID-19: A Systematic Review and Me-ta-Analysis. Reviews in Medical Virology, 32, e2304.
|
[46]
|
Wong, J.Y., Tan, M., Zheng, Q., et al. (2020) A Systematic Review and Meta-Analysis of the COVID-19 Associated Liver Injury. Annals of Hepatology, 19, 627-634. https://doi.org/10.1016/j.aohep.2020.08.064
|
[47]
|
Dong, X., Zeng, D.-Y., Xing, Q.-Q., et al. (2022) Liver Chem-istries in Severe or Non-Severe Cases of COVID-19: A Systematic Review and Meta-Analysis. World Journal of Hepatology, 14, 2012-2024.
https://doi.org/10.4254/wjh.v14.i12.2012
|
[48]
|
Kheir, M., et al. (2021) Higher Albumin Levels on Admission Predict Better Prognosis in Patients with Confirmed COVID-19. PLOS ONE, 16, e0248358. https://doi.org/10.1371/journal.pone.0248358
|
[49]
|
Zekri-Nechar, K., Zamorano-León, J.J., Segura-Fragoso, A., et al. (2022) Albumin Binds COVID-19 Spike 1 Subunit and Predicts In-Hospital Survival of Infected Patients—Possible Alteration by Glucose. Journal of Clinical Medicine, 11, 587. https://doi.org/10.3390/jcm11030587
|
[50]
|
Ertekin, B. and Acar, T. (2023) The Relationship between Albumin and Its Proportion to Other Markers in Predicting Mortality in Severe COVID-19 Patients. European Review for Medical and Pharmacological Sciences, 27, 6429-6436.
|
[51]
|
Xie, C.Y., Wang, S.J., Zhou, J., et al. (2022) Albumin Level as an Independent Predictive Factor for Adverse Outcomes in COVID-19 Patients: A Retrospective Cohort Study. Journal of Infection in Developing Countries, 16, 1696-1702.
https://doi.org/10.3855/jidc.16880
|
[52]
|
Yao, X.H., Li, T.Y., He, Z.C., et al. (2020) A Pathological Report of Three COVID-19 Cases by Minimal Invasive Autopsies. Chinese Journal of Pathology, 49, 411-417.
|
[53]
|
Tavazzi, G., Pellegrini, C., Maurelli, M., et al. (2020) Myocardial Localization of Coronavirus in COVID-19 Cardiogenic Shock. European Journal of Heart Failure, 22, 911-915. https://doi.org/10.1002/ejhf.1828
|
[54]
|
Rahman, T., Al-Ishaq, F.A., Al-Mohannadi, F.S., et al. (2021) Mortality Prediction Utilizing Blood Biomarkers to Predict the Severity of COVID-19 Using Machine Learning Technique. Diagnostics, 11, 1582-1582.
https://doi.org/10.3390/diagnostics11091582
|
[55]
|
Ozenen, G.G., Kara, A.A., Kiymet, E., et al. (2022) The Eval-uation of Troponin I Levels and Myocarditis in Children with COVID-19: A Pediatric Single-Center Experience. Pedi-atric Cardiology, 44, 873-881.
https://doi.org/10.1007/s00246-022-03017-5
|
[56]
|
Patel, T., Kelleman, M., West, Z., et al. (2022) Comparison of Multisystem Inflammatory Syndrome in Children-Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vac-cine-Related Myocarditis in Children. Journal of the American Heart Association, 11, e024393. https://doi.org/10.1161/JAHA.121.024393
|
[57]
|
Lara, D., Young, T., Del Toro, K., et al. (2020) Acute Fulminant Myocarditis in a Pediatric Patient with COVID-19 Infection. Pediatrics, 146, e20201509. https://doi.org/10.1542/peds.2020-1509
|
[58]
|
Sirico, D., Basso, A., Sabatino, J., et al. (2022) Evolution of Echo-cardiographic and Cardiac Magnetic Resonance Imaging Abnormalities during Follow-Up in Patients with Multisystem Inflammatory Syndrome in Children. European Heart Journal. Cardiovascular Imaging, 23, 1066-1074. https://doi.org/10.1093/ehjci/jeac096
|
[59]
|
Güllü, U.U., Güngör, Ş., İpek, S., et al. (2021) Predictive Value of Cardiac Markers in the Prognosis of COVID-19 in Children. American Journal of Emergency Medicine, 48, 307-311. https://doi.org/10.1016/j.ajem.2021.06.075
|
[60]
|
Rodriguez-Gonzalez, M., Castellano-Martinez, A., Maria Cascales-Poyatos, H., et al. (2020) Cardiovascular Impact of COVID-19 with a Focus on Children: A Systematic Re-view. World Journal of Clinical Cases, 8, 5250-5283.
https://doi.org/10.12998/wjcc.v8.i21.5250
|
[61]
|
Liu, A., et al. (2023) Normal High-Sensitivity Cardiac Troponin for Ruling-Out Inpatient Mortality in Acute COVID-19. PLOS ONE, 18, e0284523. https://doi.org/10.1371/journal.pone.0284523
|
[62]
|
Gupta, P., Gupta, A., Bansal, S. and Balakrishnan, I. (2023) Cardiac Troponin in Hospitalized COVID-19 Patients: Incidence, Predictors, and Outcomes. Annals of Clinical Bio-chemistry.
|
[63]
|
Orlando, L., et al. (2023) Natural Course of COVID-19 and Independent Predictors of Mortality. Bio-medicines, 11, 939-939. https://doi.org/10.3390/biomedicines11030939
|
[64]
|
Cilingir, B.M., Askar, S., Meral, A. and Askar, M. (2022) Can B-Type Natriuretic Peptide (BNP) Levels Serve as an Early Predictor of Clinical Severity in Patients with COVID-19 Pneumonia? Clinical Laboratory, 68, No. 1.
https://doi.org/10.7754/Clin.Lab.2021.210602
|
[65]
|
Fawzy, M., Ahmed, S.S. and Abdelhady, S.A. (2023) As-sessment of Diagnostic and Prognostic Laboratory Biomarkers in Severe COVID-19 Patients Admitted to Intensive Care Unit. The Egyptian Journal of Immunology, 30, 11-13.
https://doi.org/10.55133/eji.300101
|